Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.31 - $0.84 $5,909 - $16,012
19,062 New
19,062 $9,000
Q3 2021

Nov 15, 2021

SELL
$4.61 - $6.56 $3,457 - $4,920
-750 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$4.71 - $6.95 $3,532 - $5,212
750 New
750 $5,000

Others Institutions Holding VIRI

About Virios Therapeutics, Inc.


  • Ticker VIRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,330,400
  • Market Cap $81.4M
  • Description
  • Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...
More about VIRI
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.